Supernus Pharmaceuticals
SUPN
SUPN
325 hedge funds and large institutions have $3.01B invested in Supernus Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 116 increasing their positions, 116 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
0% more repeat investments, than reductions
Existing positions increased: 116 | Existing positions reduced: 116
2% less funds holding
Funds holding: 332 → 325 (-7)
41% less call options, than puts
Call options by funds: $3.42M | Put options by funds: $5.84M
Holders
325
Holding in Top 10
3
Calls
$3.42M
Puts
$5.84M
Top Buyers
| 1 | +$53M | |
| 2 | +$34.4M | |
| 3 | +$27M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$22.9M |
| 5 |
FGP
Freestone Grove Partners
San Francisco,
California
|
+$22.7M |
Top Sellers
| 1 | -$48.2M | |
| 2 | -$44.2M | |
| 3 | -$20.6M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$14.7M |
| 5 |
NAMI
Nomura Asset Management International
Philadelphia,
Pennsylvania
|
-$13.8M |
